AT
The startup develops targeted therapeutics that utilize gene editing techniques to treat cancer, focusing on genetic alterations that conventional therapies cannot reach. This approach enables patients to receive personalized treatment options that improve their health outcomes and quality of life.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops targeted therapeutics that utilize gene editing techniques to treat cancer, focusing on genetic alterations that conventional therapies cannot reach. This approach enables patients to receive personalized treatment options that improve their health outcomes and quality of life.